Evidence map›Paper›PMID 27502570›Full record

ArticleVaccine2016

Live-vaccinia virus encapsulation in pH-sensitive polymer increases safety of a reservoir-targeted Lyme disease vaccine by targeting gastrointestinal release.

Aurelie Kern, Chensheng W Zhou, Feng Jia, Qiaobing Xu, Linden T Hu

Abstract read
In one paragraph

Article in Vaccine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Eliminating Factor H-Binding Activity ofFrontiers in immunology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Aurelie KernDepartment of Molecular Biology and Microbiology, Tufts University, Boston, USA.
Chensheng W ZhouDepartment of Biomedical Engineering, Tufts University, Medford, USA.
Feng JiaDepartment of Biomedical Engineering, Tufts University, Medford, USA.
Qiaobing XuDepartment of Biomedical Engineering, Tufts University, Medford, USA.
Linden T HuDepartment of Molecular Biology and Microbiology, Tufts University, Boston, USA. Electronic address: linden.hu@tufts.edu.
Tufts University · US

Funding

Vaccines and Diagnostics TrialsU54AI065359 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI BARBOUR, ALAN G. · 2005 to 2013
$88.8M
Delivery system development for a reservoir targeted Lyme disease vaccineR42AI078631 · NIAID · FOODSOURCE LURE CORPORATION · PI HU, LINDEN T · 2012 to 2014
$3.0M
Delivery system development for a reservoir targeted Lyme disease vaccineR41AI078631 · NIAID · FOODSOURCE LURE CORPORATION · PI HU, LINDEN T · 2008 to 2009
$600k
NIAID NIH HHS R41 AI078631NIAID NIH HHS R42 AI078631NIAID NIH HHS U54 AI065359
6 · The paper itself

Abstract

The incidence of Lyme disease has continued to rise despite attempts to control its spread. Vaccination of zoonotic reservoirs of human pathogens has been successfully used to decrease the incidence of rabies in raccoons and foxes. We have previously reported on the efficacy of a vaccinia virus vectored vaccine to reduce carriage of Borrelia burgdorferi in reservoir mice and ticks. One potential drawback to vaccinia virus vectored vaccines is the risk of accidental infection of humans. To reduce this risk, we developed a process to encapsulate vaccinia virus with a pH-sensitive polymer that inactivates the virus until it is ingested and dissolved by stomach acids. We demonstrate that the vaccine is inactive both in vitro and in vivo until it is released from the polymer. Once released from the polymer by contact with an acidic pH solution, the virus regains infectivity. Vaccination with coated vaccinia virus confers protection against B. burgdorferi infection and reduction in acquisition of the pathogen by naïve feeding ticks.

Indexed as

Vaccinia virusAcrylatesAdministration, OralAnimalsAntibodies, BacterialAntibody FormationDisease ReservoirsDrug CompoundingGastrointestinal TractHydrogen-Ion ConcentrationIxodesLyme DiseaseLyme Disease VaccinesMiceMice, Inbred BALB CMice, Inbred C3HAcrylatesAntibodies, BacterialEudragit E100Lyme Disease VaccinesPolymersBorrelia burgdorferiEncapsulationLyme diseasePolymethylacrylateReservoir-targeted vaccineSafety

Identifiers

PMID27502570
PMCPMC4996687
OpenAlexW2493586648

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.